Sources | Names Used |
---|---|
CTRPv2 | UNC0638:navitoclax (1:1 mol/mol) |
PharmacoGx | UNC0638:navitoclax (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ARHGAP33 | CTRPv2 | pan-cancer | AAC | 0.36 | 1e-22 |
mRNA | YPEL1 | CTRPv2 | pan-cancer | AAC | 0.34 | 1e-19 |
mRNA | ZNF737 | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-18 |
mRNA | RP11-729L2.2 | CTRPv2 | pan-cancer | AAC | 0.33 | 5e-17 |
mRNA | CELF4 | CTRPv2 | pan-cancer | AAC | 0.31 | 6e-17 |
mRNA | CRMP1 | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-16 |
mRNA | CBFA2T2 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-16 |
mRNA | SMAD4 | CTRPv2 | pan-cancer | AAC | 0.32 | 2e-16 |
mRNA | PRR36 | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-16 |
mRNA | TAGLN3 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-15 |